Science

Nine in ten Acinetobacter samples resist powerful carbapenem antibiotics in Indian hospitals

ICMR network analysed more than 130 000 cultures from 64 hospitals, prescribed remedy remains advice against self-medication and shared prescriptions

Images

Antibiotic Resistance mentioned in ICMR report 2025 (Credits: iStock) Antibiotic Resistance mentioned in ICMR report 2025 (Credits: iStock) timesnownews.com
Two Indian Origin Persons Killed In 'Targeted' Shooting Outside Canada Walmart: Report Two Indian Origin Persons Killed In 'Targeted' Shooting Outside Canada Walmart: Report timesnownews.com

More than nine in ten Acinetobacter baumannii samples tested in Indian hospitals resisted carbapenems, a powerful class of antibiotics used against serious infections, according to the Indian Council of Medical Research's 2025 surveillance report. The network analysed more than 133,000 culture-positive samples from 64 hospitals across the country. Among E. coli samples, just 18.4 percent remained susceptible to cefotaxime, a commonly used antibiotic.

One point the report labours to correct: bodies do not become resistant to antibiotics, bacteria do. Every unnecessary course kills the susceptible bacteria and leaves those carrying resistance mechanisms free to multiply. The doctors quoted alongside the data describe the consequences plainly. Dr. Rakesh Gupta, senior consultant in internal medicine at Indraprastha Apollo Hospital in Delhi, says that when antibiotics stop working, illnesses lengthen, recovery is delayed and stronger or alternative treatments become necessary. Dr. Sumit Aggarwal of Sarvodaya Hospital in Faridabad adds that unnecessary use disturbs the intestinal microbiome and brings side effects from nausea and diarrhoea to allergic reactions.

The remedies on offer are instructions to individuals: take antibiotics only when prescribed, follow the dose and duration, do not save leftovers, do not share prescriptions, do not self-medicate. That the advice needs stating at all describes the environment the 64 hospitals are sampling. A patient who takes an antibiotic without medical indication bears a course of side effects; the resistance it selects travels through homes, workplaces and communities to people who never took the pill. Both doctors call resistance a public health issue rather than an individual one — the people who pay for each unnecessary course are mostly not the people who took it.

The network exists to measure that transfer, at the scale of 133,000 samples. The instructions it accompanies are the same ones doctors have issued for decades. The susceptibility tables, by the report's own account, are not standing still.